Chronic or persistent pain is a common — and likely under-recognized — complication of ischemic strokes (caused by a blocked blood vessel) according to new research in the American Heart Association journal Stroke .
In a large trial of treatments to prevent a second stroke, researchers found that 10.6 percent of more than 15,000 stroke survivors developed chronic pain.
"Chronic pain syndromes are common, even following strokes of mild to moderate severity," said Martin J. O'Donnell, M.D., lead author and professor of translational medicine at the National University of Ireland in Galway and associate clinical professor at McMaster University in Hamilton, Ontario, Canada. "It is associated with greater decline in physical and cognitive function, making it an important medical complication after stroke."
Researchers examined data on 15,754 people who had survived mild to moderate strokes and were followed for an average 30 months in PRoFESS (Prevention Regimen for Effectively Avoiding Second Strokes), the largest study to determine the prevalence of chronic pain after ischemic stroke.
Of the 1,665 stroke survivors reporting chronic pain beginning after their stroke:
Significant risk factors for post-stroke pain included increased severity of stroke; female gender; greater alcohol intake; recent symptoms of depression; diabetes and vascular disease of blood vessels supplying the lower limbs.
Patients who developed post-stroke chronic pain were more than twice as likely to become more dependent during the follow-up period, than those whose recovery wasn't complicated by pain. Patients with non-central causes of pain were more likely to experience cognitive decline.
"We suspect that some of the association between chronic pain and decline in cognitive test performance may be related to the use of medications to treat pain, but this was not evaluated in our study" said O'Donnell. "Our study emphasizes the importance of evaluating interventions to prevent post-stroke pain in high-risk individuals."
Co-authors are: Hans-Christoph Diener, M.D.; Ralph L. Sacco, M.D.; Akbar A. Panju, M.D.; Richard Vinisko, M.A.; and Salim Yusuf, M.D., D.Phil. Author disclosures are on the manuscript.
Boehringer-Ingelhain funded the study.
For the latest heart and stroke news, follow @HeartNews on Twitter.
For stroke science, follow the Stroke journal at @StrokeAHA_ASA
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding .
Stroke